Details for New Drug Application (NDA): 083892
✉ Email this page to a colleague
NDA 083892 describes EXSEL, which is a drug marketed by Allergan Herbert and is included in one NDA. Additional details are available on the EXSEL profile page.
The generic ingredient in EXSEL is selenium sulfide. There are eight drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the selenium sulfide profile page.
The generic ingredient in EXSEL is selenium sulfide. There are eight drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the selenium sulfide profile page.
Summary for 083892
| Tradename: | EXSEL |
| Applicant: | Allergan Herbert |
| Ingredient: | selenium sulfide |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 083892
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | LOTION/SHAMPOO;TOPICAL | Strength | 2.5% | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
